nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—ALB—multiple sclerosis	0.337	1	CbGaD
Rosiglitazone—CYP2A6—Prednisolone—multiple sclerosis	0.0796	0.195	CbGbCtD
Rosiglitazone—CYP2D6—Fingolimod—multiple sclerosis	0.0606	0.149	CbGbCtD
Rosiglitazone—ALB—Prednisone—multiple sclerosis	0.048	0.118	CbGbCtD
Rosiglitazone—CYP2A6—Dexamethasone—multiple sclerosis	0.0469	0.115	CbGbCtD
Rosiglitazone—SLCO1B1—Methotrexate—multiple sclerosis	0.044	0.108	CbGbCtD
Rosiglitazone—CYP2C19—Prednisone—multiple sclerosis	0.0311	0.0763	CbGbCtD
Rosiglitazone—ALB—Methotrexate—multiple sclerosis	0.0241	0.059	CbGbCtD
Rosiglitazone—CYP2C8—Dexamethasone—multiple sclerosis	0.0231	0.0568	CbGbCtD
Rosiglitazone—CYP2C19—Dexamethasone—multiple sclerosis	0.0194	0.0476	CbGbCtD
Rosiglitazone—CYP2C9—Dexamethasone—multiple sclerosis	0.0161	0.0396	CbGbCtD
Rosiglitazone—CYP2D6—Dexamethasone—multiple sclerosis	0.0148	0.0362	CbGbCtD
Rosiglitazone—PPARG—leg—multiple sclerosis	0.00202	0.209	CbGeAlD
Rosiglitazone—ACSL4—retina—multiple sclerosis	0.00101	0.104	CbGeAlD
Rosiglitazone—ACSL4—medulla oblongata—multiple sclerosis	0.000731	0.0754	CbGeAlD
Rosiglitazone—ACSL4—midbrain—multiple sclerosis	0.000668	0.0689	CbGeAlD
Rosiglitazone—ACSL4—spinal cord—multiple sclerosis	0.000652	0.0673	CbGeAlD
Rosiglitazone—Diabetes mellitus—Dexamethasone—multiple sclerosis	0.000624	0.00336	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Betamethasone—multiple sclerosis	0.000624	0.00336	CcSEcCtD
Rosiglitazone—Weight increased—Mitoxantrone—multiple sclerosis	0.000623	0.00336	CcSEcCtD
Rosiglitazone—Arthralgia—Cladribine—multiple sclerosis	0.000618	0.00333	CcSEcCtD
Rosiglitazone—Myalgia—Cladribine—multiple sclerosis	0.000618	0.00333	CcSEcCtD
Rosiglitazone—Fluid retention—Prednisone—multiple sclerosis	0.000618	0.00333	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.000618	0.00333	CcSEcCtD
Rosiglitazone—Immune system disorder—Azathioprine—multiple sclerosis	0.000613	0.0033	CcSEcCtD
Rosiglitazone—Cardiac failure—Methylprednisolone—multiple sclerosis	0.000611	0.0033	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.000602	0.00325	CcSEcCtD
Rosiglitazone—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.000599	0.00323	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Betamethasone—multiple sclerosis	0.000598	0.00323	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Dexamethasone—multiple sclerosis	0.000598	0.00323	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Methotrexate—multiple sclerosis	0.000598	0.00323	CcSEcCtD
Rosiglitazone—Oedema—Cladribine—multiple sclerosis	0.000593	0.0032	CcSEcCtD
Rosiglitazone—Infection—Cladribine—multiple sclerosis	0.000589	0.00318	CcSEcCtD
Rosiglitazone—Nervous system disorder—Cladribine—multiple sclerosis	0.000581	0.00313	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Cladribine—multiple sclerosis	0.00058	0.00313	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Prednisone—multiple sclerosis	0.000579	0.00313	CcSEcCtD
Rosiglitazone—Increased appetite—Betamethasone—multiple sclerosis	0.000578	0.00311	CcSEcCtD
Rosiglitazone—Increased appetite—Dexamethasone—multiple sclerosis	0.000578	0.00311	CcSEcCtD
Rosiglitazone—Hepatic enzyme increased—Methotrexate—multiple sclerosis	0.000575	0.0031	CcSEcCtD
Rosiglitazone—Sinusitis—Mitoxantrone—multiple sclerosis	0.000573	0.00309	CcSEcCtD
Rosiglitazone—Cardiac failure—Dexamethasone—multiple sclerosis	0.000556	0.003	CcSEcCtD
Rosiglitazone—Cardiac failure—Betamethasone—multiple sclerosis	0.000556	0.003	CcSEcCtD
Rosiglitazone—ACSL4—nervous system—multiple sclerosis	0.000549	0.0567	CbGeAlD
Rosiglitazone—Hepatitis—Mitoxantrone—multiple sclerosis	0.000548	0.00296	CcSEcCtD
Rosiglitazone—Anaemia—Azathioprine—multiple sclerosis	0.000546	0.00294	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Prednisone—multiple sclerosis	0.000543	0.00293	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00054	0.00291	CcSEcCtD
Rosiglitazone—Leukopenia—Azathioprine—multiple sclerosis	0.000529	0.00285	CcSEcCtD
Rosiglitazone—ACSL4—central nervous system—multiple sclerosis	0.000529	0.0546	CbGeAlD
Rosiglitazone—Cardiac failure congestive—Prednisone—multiple sclerosis	0.000521	0.00281	CcSEcCtD
Rosiglitazone—ACSL4—cerebellum—multiple sclerosis	0.000517	0.0533	CbGeAlD
Rosiglitazone—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000512	0.00276	CcSEcCtD
Rosiglitazone—Weight increased—Prednisolone—multiple sclerosis	0.000512	0.00276	CcSEcCtD
Rosiglitazone—Fatigue—Cladribine—multiple sclerosis	0.000511	0.00276	CcSEcCtD
Rosiglitazone—Constipation—Cladribine—multiple sclerosis	0.000507	0.00273	CcSEcCtD
Rosiglitazone—Increased appetite—Prednisone—multiple sclerosis	0.000503	0.00271	CcSEcCtD
Rosiglitazone—Myalgia—Azathioprine—multiple sclerosis	0.000503	0.00271	CcSEcCtD
Rosiglitazone—Arthralgia—Azathioprine—multiple sclerosis	0.000503	0.00271	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000494	0.00266	CcSEcCtD
Rosiglitazone—Myocardial infarction—Prednisolone—multiple sclerosis	0.000491	0.00265	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Methotrexate—multiple sclerosis	0.000484	0.00261	CcSEcCtD
Rosiglitazone—Cardiac failure—Prednisone—multiple sclerosis	0.000484	0.00261	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00048	0.00259	CcSEcCtD
Rosiglitazone—Infection—Azathioprine—multiple sclerosis	0.000479	0.00258	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000472	0.00254	CcSEcCtD
Rosiglitazone—Urticaria—Cladribine—multiple sclerosis	0.000471	0.00254	CcSEcCtD
Rosiglitazone—Weight increased—Triamcinolone—multiple sclerosis	0.00047	0.00254	CcSEcCtD
Rosiglitazone—Weight increased—Methylprednisolone—multiple sclerosis	0.000469	0.00253	CcSEcCtD
Rosiglitazone—Back pain—Mitoxantrone—multiple sclerosis	0.000462	0.00249	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000454	0.00245	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Methotrexate—multiple sclerosis	0.000454	0.00245	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000453	0.00244	CcSEcCtD
Rosiglitazone—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000452	0.00244	CcSEcCtD
Rosiglitazone—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000451	0.00243	CcSEcCtD
Rosiglitazone—Anaemia—Mitoxantrone—multiple sclerosis	0.000441	0.00238	CcSEcCtD
Rosiglitazone—Hepatic failure—Methotrexate—multiple sclerosis	0.000439	0.00237	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000439	0.00237	CcSEcCtD
Rosiglitazone—Leukopenia—Mitoxantrone—multiple sclerosis	0.000427	0.0023	CcSEcCtD
Rosiglitazone—Weight increased—Dexamethasone—multiple sclerosis	0.000427	0.0023	CcSEcCtD
Rosiglitazone—Weight increased—Betamethasone—multiple sclerosis	0.000427	0.0023	CcSEcCtD
Rosiglitazone—Asthenia—Cladribine—multiple sclerosis	0.000425	0.00229	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000423	0.00228	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000423	0.00228	CcSEcCtD
Rosiglitazone—ACSL4—brain—multiple sclerosis	0.00042	0.0433	CbGeAlD
Rosiglitazone—Pruritus—Cladribine—multiple sclerosis	0.000419	0.00226	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000416	0.00224	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000412	0.00222	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000412	0.00222	CcSEcCtD
Rosiglitazone—Hypertension—Mitoxantrone—multiple sclerosis	0.000412	0.00222	CcSEcCtD
Rosiglitazone—Myocardial infarction—Dexamethasone—multiple sclerosis	0.00041	0.00221	CcSEcCtD
Rosiglitazone—Myocardial infarction—Betamethasone—multiple sclerosis	0.00041	0.00221	CcSEcCtD
Rosiglitazone—Myalgia—Mitoxantrone—multiple sclerosis	0.000406	0.00219	CcSEcCtD
Rosiglitazone—Arthralgia—Mitoxantrone—multiple sclerosis	0.000406	0.00219	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000406	0.00219	CcSEcCtD
Rosiglitazone—Diarrhoea—Cladribine—multiple sclerosis	0.000406	0.00219	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000403	0.00217	CcSEcCtD
Rosiglitazone—Dizziness—Cladribine—multiple sclerosis	0.000392	0.00211	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00039	0.0021	CcSEcCtD
Rosiglitazone—Oedema—Mitoxantrone—multiple sclerosis	0.00039	0.0021	CcSEcCtD
Rosiglitazone—Infection—Mitoxantrone—multiple sclerosis	0.000387	0.00209	CcSEcCtD
Rosiglitazone—Eye disorder—Methylprednisolone—multiple sclerosis	0.000386	0.00208	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000383	0.00207	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000381	0.00206	CcSEcCtD
Rosiglitazone—Rash—Cladribine—multiple sclerosis	0.000374	0.00202	CcSEcCtD
Rosiglitazone—Dermatitis—Cladribine—multiple sclerosis	0.000373	0.00201	CcSEcCtD
Rosiglitazone—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000373	0.00201	CcSEcCtD
Rosiglitazone—Weight increased—Prednisone—multiple sclerosis	0.000372	0.002	CcSEcCtD
Rosiglitazone—Headache—Cladribine—multiple sclerosis	0.000371	0.002	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Prednisone—multiple sclerosis	0.000368	0.00199	CcSEcCtD
Rosiglitazone—Malnutrition—Methylprednisolone—multiple sclerosis	0.000359	0.00194	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000359	0.00194	CcSEcCtD
Rosiglitazone—Angioedema—Prednisolone—multiple sclerosis	0.000358	0.00193	CcSEcCtD
Rosiglitazone—Myocardial infarction—Prednisone—multiple sclerosis	0.000357	0.00193	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000355	0.00191	CcSEcCtD
Rosiglitazone—Nausea—Cladribine—multiple sclerosis	0.000352	0.0019	CcSEcCtD
Rosiglitazone—Eye disorder—Betamethasone—multiple sclerosis	0.000351	0.00189	CcSEcCtD
Rosiglitazone—Eye disorder—Dexamethasone—multiple sclerosis	0.000351	0.00189	CcSEcCtD
Rosiglitazone—Back pain—Triamcinolone—multiple sclerosis	0.000348	0.00188	CcSEcCtD
Rosiglitazone—Hypertension—Prednisolone—multiple sclerosis	0.000338	0.00182	CcSEcCtD
Rosiglitazone—Fatigue—Mitoxantrone—multiple sclerosis	0.000336	0.00181	CcSEcCtD
Rosiglitazone—Constipation—Mitoxantrone—multiple sclerosis	0.000333	0.0018	CcSEcCtD
Rosiglitazone—Diarrhoea—Azathioprine—multiple sclerosis	0.00033	0.00178	CcSEcCtD
Rosiglitazone—Angioedema—Triamcinolone—multiple sclerosis	0.000329	0.00177	CcSEcCtD
Rosiglitazone—Angioedema—Methylprednisolone—multiple sclerosis	0.000328	0.00177	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Prednisone—multiple sclerosis	0.000321	0.00173	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00032	0.00172	CcSEcCtD
Rosiglitazone—Oedema—Prednisolone—multiple sclerosis	0.00032	0.00172	CcSEcCtD
Rosiglitazone—Dizziness—Azathioprine—multiple sclerosis	0.000319	0.00172	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000317	0.00171	CcSEcCtD
Rosiglitazone—Hypertension—Triamcinolone—multiple sclerosis	0.000311	0.00168	CcSEcCtD
Rosiglitazone—Hypertension—Methylprednisolone—multiple sclerosis	0.00031	0.00167	CcSEcCtD
Rosiglitazone—Urticaria—Mitoxantrone—multiple sclerosis	0.000309	0.00167	CcSEcCtD
Rosiglitazone—Myalgia—Triamcinolone—multiple sclerosis	0.000307	0.00165	CcSEcCtD
Rosiglitazone—Myalgia—Methylprednisolone—multiple sclerosis	0.000306	0.00165	CcSEcCtD
Rosiglitazone—Arthralgia—Methylprednisolone—multiple sclerosis	0.000306	0.00165	CcSEcCtD
Rosiglitazone—Eye disorder—Prednisone—multiple sclerosis	0.000306	0.00165	CcSEcCtD
Rosiglitazone—Rash—Azathioprine—multiple sclerosis	0.000304	0.00164	CcSEcCtD
Rosiglitazone—Dermatitis—Azathioprine—multiple sclerosis	0.000304	0.00164	CcSEcCtD
Rosiglitazone—Headache—Azathioprine—multiple sclerosis	0.000302	0.00163	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000302	0.00163	CcSEcCtD
Rosiglitazone—Angioedema—Dexamethasone—multiple sclerosis	0.000299	0.00161	CcSEcCtD
Rosiglitazone—Angioedema—Betamethasone—multiple sclerosis	0.000299	0.00161	CcSEcCtD
Rosiglitazone—Immune system disorder—Prednisone—multiple sclerosis	0.000295	0.00159	CcSEcCtD
Rosiglitazone—Oedema—Triamcinolone—multiple sclerosis	0.000294	0.00159	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000294	0.00159	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000293	0.00158	CcSEcCtD
Rosiglitazone—Infection—Triamcinolone—multiple sclerosis	0.000292	0.00157	CcSEcCtD
Rosiglitazone—Infection—Methylprednisolone—multiple sclerosis	0.000291	0.00157	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000288	0.00155	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000288	0.00155	CcSEcCtD
Rosiglitazone—Nausea—Azathioprine—multiple sclerosis	0.000286	0.00154	CcSEcCtD
Rosiglitazone—Malnutrition—Prednisone—multiple sclerosis	0.000285	0.00153	CcSEcCtD
Rosiglitazone—Hypertension—Betamethasone—multiple sclerosis	0.000282	0.00152	CcSEcCtD
Rosiglitazone—Hypertension—Dexamethasone—multiple sclerosis	0.000282	0.00152	CcSEcCtD
Rosiglitazone—Asthenia—Mitoxantrone—multiple sclerosis	0.00028	0.00151	CcSEcCtD
Rosiglitazone—Myalgia—Betamethasone—multiple sclerosis	0.000278	0.0015	CcSEcCtD
Rosiglitazone—Myalgia—Dexamethasone—multiple sclerosis	0.000278	0.0015	CcSEcCtD
Rosiglitazone—Hepatitis—Methotrexate—multiple sclerosis	0.000273	0.00147	CcSEcCtD
Rosiglitazone—CYP2A6—cerebellum—multiple sclerosis	0.000273	0.0282	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000268	0.00144	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000267	0.00144	CcSEcCtD
Rosiglitazone—Oedema—Dexamethasone—multiple sclerosis	0.000267	0.00144	CcSEcCtD
Rosiglitazone—Oedema—Betamethasone—multiple sclerosis	0.000267	0.00144	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000267	0.00144	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000267	0.00144	CcSEcCtD
Rosiglitazone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000267	0.00144	CcSEcCtD
Rosiglitazone—Infection—Betamethasone—multiple sclerosis	0.000265	0.00143	CcSEcCtD
Rosiglitazone—Infection—Dexamethasone—multiple sclerosis	0.000265	0.00143	CcSEcCtD
Rosiglitazone—Anaemia—Prednisone—multiple sclerosis	0.000263	0.00142	CcSEcCtD
Rosiglitazone—Nervous system disorder—Betamethasone—multiple sclerosis	0.000262	0.00141	CcSEcCtD
Rosiglitazone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000262	0.00141	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000261	0.00141	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000261	0.00141	CcSEcCtD
Rosiglitazone—Angioedema—Prednisone—multiple sclerosis	0.00026	0.0014	CcSEcCtD
Rosiglitazone—Erythema multiforme—Methotrexate—multiple sclerosis	0.000258	0.00139	CcSEcCtD
Rosiglitazone—Eye disorder—Methotrexate—multiple sclerosis	0.000255	0.00138	CcSEcCtD
Rosiglitazone—Urticaria—Prednisolone—multiple sclerosis	0.000254	0.00137	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methotrexate—multiple sclerosis	0.000254	0.00137	CcSEcCtD
Rosiglitazone—Fatigue—Triamcinolone—multiple sclerosis	0.000253	0.00137	CcSEcCtD
Rosiglitazone—Fatigue—Methylprednisolone—multiple sclerosis	0.000253	0.00136	CcSEcCtD
Rosiglitazone—PPARG—nervous system—multiple sclerosis	0.000247	0.0255	CbGeAlD
Rosiglitazone—Immune system disorder—Methotrexate—multiple sclerosis	0.000247	0.00133	CcSEcCtD
Rosiglitazone—Hypertension—Prednisone—multiple sclerosis	0.000246	0.00133	CcSEcCtD
Rosiglitazone—Rash—Mitoxantrone—multiple sclerosis	0.000246	0.00132	CcSEcCtD
Rosiglitazone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000245	0.00132	CcSEcCtD
Rosiglitazone—Headache—Mitoxantrone—multiple sclerosis	0.000244	0.00132	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000243	0.00131	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000243	0.00131	CcSEcCtD
Rosiglitazone—Myalgia—Prednisone—multiple sclerosis	0.000242	0.00131	CcSEcCtD
Rosiglitazone—Arthralgia—Prednisone—multiple sclerosis	0.000242	0.00131	CcSEcCtD
Rosiglitazone—Malnutrition—Methotrexate—multiple sclerosis	0.000238	0.00128	CcSEcCtD
Rosiglitazone—PPARG—central nervous system—multiple sclerosis	0.000238	0.0245	CbGeAlD
Rosiglitazone—Urticaria—Triamcinolone—multiple sclerosis	0.000233	0.00126	CcSEcCtD
Rosiglitazone—Urticaria—Methylprednisolone—multiple sclerosis	0.000233	0.00126	CcSEcCtD
Rosiglitazone—Oedema—Prednisone—multiple sclerosis	0.000232	0.00125	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisone—multiple sclerosis	0.000232	0.00125	CcSEcCtD
Rosiglitazone—Nausea—Mitoxantrone—multiple sclerosis	0.000231	0.00125	CcSEcCtD
Rosiglitazone—Infection—Prednisone—multiple sclerosis	0.000231	0.00124	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00023	0.00124	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00023	0.00124	CcSEcCtD
Rosiglitazone—Back pain—Methotrexate—multiple sclerosis	0.00023	0.00124	CcSEcCtD
Rosiglitazone—Fatigue—Betamethasone—multiple sclerosis	0.00023	0.00124	CcSEcCtD
Rosiglitazone—Fatigue—Dexamethasone—multiple sclerosis	0.00023	0.00124	CcSEcCtD
Rosiglitazone—Nervous system disorder—Prednisone—multiple sclerosis	0.000228	0.00123	CcSEcCtD
Rosiglitazone—CYP2A6—brain—multiple sclerosis	0.000222	0.0229	CbGeAlD
Rosiglitazone—Anaemia—Methotrexate—multiple sclerosis	0.00022	0.00119	CcSEcCtD
Rosiglitazone—Leukopenia—Methotrexate—multiple sclerosis	0.000213	0.00115	CcSEcCtD
Rosiglitazone—Urticaria—Dexamethasone—multiple sclerosis	0.000212	0.00114	CcSEcCtD
Rosiglitazone—Urticaria—Betamethasone—multiple sclerosis	0.000212	0.00114	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000212	0.00114	CcSEcCtD
Rosiglitazone—Dizziness—Prednisolone—multiple sclerosis	0.000211	0.00114	CcSEcCtD
Rosiglitazone—Asthenia—Triamcinolone—multiple sclerosis	0.000211	0.00114	CcSEcCtD
Rosiglitazone—Asthenia—Methylprednisolone—multiple sclerosis	0.00021	0.00113	CcSEcCtD
Rosiglitazone—Pruritus—Triamcinolone—multiple sclerosis	0.000208	0.00112	CcSEcCtD
Rosiglitazone—Pruritus—Methylprednisolone—multiple sclerosis	0.000207	0.00112	CcSEcCtD
Rosiglitazone—CYP2D6—brainstem—multiple sclerosis	0.000207	0.0214	CbGeAlD
Rosiglitazone—Arthralgia—Methotrexate—multiple sclerosis	0.000202	0.00109	CcSEcCtD
Rosiglitazone—Myalgia—Methotrexate—multiple sclerosis	0.000202	0.00109	CcSEcCtD
Rosiglitazone—Rash—Prednisolone—multiple sclerosis	0.000202	0.00109	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisolone—multiple sclerosis	0.000201	0.00109	CcSEcCtD
Rosiglitazone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000201	0.00108	CcSEcCtD
Rosiglitazone—Fatigue—Prednisone—multiple sclerosis	0.0002	0.00108	CcSEcCtD
Rosiglitazone—Headache—Prednisolone—multiple sclerosis	0.0002	0.00108	CcSEcCtD
Rosiglitazone—Constipation—Prednisone—multiple sclerosis	0.000199	0.00107	CcSEcCtD
Rosiglitazone—Dizziness—Triamcinolone—multiple sclerosis	0.000194	0.00105	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000194	0.00105	CcSEcCtD
Rosiglitazone—Dizziness—Methylprednisolone—multiple sclerosis	0.000194	0.00105	CcSEcCtD
Rosiglitazone—Infection—Methotrexate—multiple sclerosis	0.000193	0.00104	CcSEcCtD
Rosiglitazone—Asthenia—Betamethasone—multiple sclerosis	0.000191	0.00103	CcSEcCtD
Rosiglitazone—Asthenia—Dexamethasone—multiple sclerosis	0.000191	0.00103	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methotrexate—multiple sclerosis	0.00019	0.00103	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00019	0.00102	CcSEcCtD
Rosiglitazone—Nausea—Prednisolone—multiple sclerosis	0.00019	0.00102	CcSEcCtD
Rosiglitazone—PPARG—brain—multiple sclerosis	0.000189	0.0195	CbGeAlD
Rosiglitazone—Pruritus—Betamethasone—multiple sclerosis	0.000189	0.00102	CcSEcCtD
Rosiglitazone—Pruritus—Dexamethasone—multiple sclerosis	0.000189	0.00102	CcSEcCtD
Rosiglitazone—Rash—Triamcinolone—multiple sclerosis	0.000185	0.000999	CcSEcCtD
Rosiglitazone—Dermatitis—Triamcinolone—multiple sclerosis	0.000185	0.000999	CcSEcCtD
Rosiglitazone—Rash—Methylprednisolone—multiple sclerosis	0.000185	0.000997	CcSEcCtD
Rosiglitazone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000185	0.000996	CcSEcCtD
Rosiglitazone—Urticaria—Prednisone—multiple sclerosis	0.000185	0.000995	CcSEcCtD
Rosiglitazone—Headache—Triamcinolone—multiple sclerosis	0.000184	0.000993	CcSEcCtD
Rosiglitazone—Headache—Methylprednisolone—multiple sclerosis	0.000184	0.000991	CcSEcCtD
Rosiglitazone—Diarrhoea—Betamethasone—multiple sclerosis	0.000182	0.000984	CcSEcCtD
Rosiglitazone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000182	0.000984	CcSEcCtD
Rosiglitazone—ALB—brain—multiple sclerosis	0.000177	0.0183	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000177	0.000954	CcSEcCtD
Rosiglitazone—Dizziness—Betamethasone—multiple sclerosis	0.000176	0.000951	CcSEcCtD
Rosiglitazone—Dizziness—Dexamethasone—multiple sclerosis	0.000176	0.000951	CcSEcCtD
Rosiglitazone—Nausea—Triamcinolone—multiple sclerosis	0.000175	0.000942	CcSEcCtD
Rosiglitazone—Nausea—Methylprednisolone—multiple sclerosis	0.000174	0.000939	CcSEcCtD
Rosiglitazone—Rash—Betamethasone—multiple sclerosis	0.000168	0.000907	CcSEcCtD
Rosiglitazone—Rash—Dexamethasone—multiple sclerosis	0.000168	0.000907	CcSEcCtD
Rosiglitazone—Dermatitis—Dexamethasone—multiple sclerosis	0.000168	0.000906	CcSEcCtD
Rosiglitazone—Dermatitis—Betamethasone—multiple sclerosis	0.000168	0.000906	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000168	0.000904	CcSEcCtD
Rosiglitazone—Fatigue—Methotrexate—multiple sclerosis	0.000167	0.000903	CcSEcCtD
Rosiglitazone—Headache—Dexamethasone—multiple sclerosis	0.000167	0.000901	CcSEcCtD
Rosiglitazone—Headache—Betamethasone—multiple sclerosis	0.000167	0.000901	CcSEcCtD
Rosiglitazone—Asthenia—Prednisone—multiple sclerosis	0.000167	0.000899	CcSEcCtD
Rosiglitazone—Pruritus—Prednisone—multiple sclerosis	0.000164	0.000886	CcSEcCtD
Rosiglitazone—Diarrhoea—Prednisone—multiple sclerosis	0.000159	0.000857	CcSEcCtD
Rosiglitazone—Nausea—Dexamethasone—multiple sclerosis	0.000158	0.000854	CcSEcCtD
Rosiglitazone—Nausea—Betamethasone—multiple sclerosis	0.000158	0.000854	CcSEcCtD
Rosiglitazone—PTGS1—spinal cord—multiple sclerosis	0.000157	0.0162	CbGeAlD
Rosiglitazone—Urticaria—Methotrexate—multiple sclerosis	0.000154	0.000832	CcSEcCtD
Rosiglitazone—Dizziness—Prednisone—multiple sclerosis	0.000154	0.000828	CcSEcCtD
Rosiglitazone—Rash—Prednisone—multiple sclerosis	0.000146	0.00079	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisone—multiple sclerosis	0.000146	0.000789	CcSEcCtD
Rosiglitazone—Headache—Prednisone—multiple sclerosis	0.000146	0.000785	CcSEcCtD
Rosiglitazone—Asthenia—Methotrexate—multiple sclerosis	0.000139	0.000751	CcSEcCtD
Rosiglitazone—Nausea—Prednisone—multiple sclerosis	0.000138	0.000744	CcSEcCtD
Rosiglitazone—Pruritus—Methotrexate—multiple sclerosis	0.000137	0.000741	CcSEcCtD
Rosiglitazone—Diarrhoea—Methotrexate—multiple sclerosis	0.000133	0.000716	CcSEcCtD
Rosiglitazone—PTGS1—nervous system—multiple sclerosis	0.000132	0.0136	CbGeAlD
Rosiglitazone—Dizziness—Methotrexate—multiple sclerosis	0.000128	0.000692	CcSEcCtD
Rosiglitazone—PTGS1—central nervous system—multiple sclerosis	0.000127	0.0131	CbGeAlD
Rosiglitazone—CYP2C8—brain—multiple sclerosis	0.000124	0.0128	CbGeAlD
Rosiglitazone—Rash—Methotrexate—multiple sclerosis	0.000122	0.00066	CcSEcCtD
Rosiglitazone—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000122	0.00204	CbGpPWpGaD
Rosiglitazone—Dermatitis—Methotrexate—multiple sclerosis	0.000122	0.000659	CcSEcCtD
Rosiglitazone—Headache—Methotrexate—multiple sclerosis	0.000122	0.000656	CcSEcCtD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000121	0.00203	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.000121	0.00201	CbGpPWpGaD
Rosiglitazone—PPARG—Signaling events mediated by HDAC Class I—STAT3—multiple sclerosis	0.000118	0.00198	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000116	0.00194	CbGpPWpGaD
Rosiglitazone—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000116	0.00193	CbGpPWpGaD
Rosiglitazone—Nausea—Methotrexate—multiple sclerosis	0.000115	0.000622	CcSEcCtD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000111	0.00185	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000111	0.00185	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000109	0.00181	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000109	0.00181	CbGpPWpGaD
Rosiglitazone—CYP2D6—nervous system—multiple sclerosis	0.000109	0.0112	CbGeAlD
Rosiglitazone—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.000108	0.0018	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000106	0.00177	CbGpPWpGaD
Rosiglitazone—CYP2D6—central nervous system—multiple sclerosis	0.000104	0.0108	CbGeAlD
Rosiglitazone—PPARG—Circadian rythm related genes—FAS—multiple sclerosis	0.000104	0.00173	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MERTK—multiple sclerosis	0.000103	0.00172	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—CD58—multiple sclerosis	0.000103	0.00172	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SELPLG—multiple sclerosis	0.000103	0.00172	CbGpPWpGaD
Rosiglitazone—PPARG—Signaling events mediated by HDAC Class I—TNF—multiple sclerosis	0.000102	0.00171	CbGpPWpGaD
Rosiglitazone—CYP2D6—cerebellum—multiple sclerosis	0.000102	0.0105	CbGeAlD
Rosiglitazone—PPARG—Developmental Biology—PRNP—multiple sclerosis	0.000102	0.0017	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000102	0.0017	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000101	0.00169	CbGpPWpGaD
Rosiglitazone—PTGS1—brain—multiple sclerosis	0.000101	0.0104	CbGeAlD
Rosiglitazone—PPARG—Metabolism—SRM—multiple sclerosis	0.0001	0.00167	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—BCHE—multiple sclerosis	0.0001	0.00167	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—ICAM1—multiple sclerosis	9.81e-05	0.00164	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—HNRNPA1—multiple sclerosis	9.75e-05	0.00163	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—U2AF2—multiple sclerosis	9.75e-05	0.00163	CbGpPWpGaD
Rosiglitazone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.74e-05	0.00163	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.66e-05	0.00161	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	9.5e-05	0.00158	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	9.24e-05	0.00154	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	9.18e-05	0.00153	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—PGR—multiple sclerosis	8.82e-05	0.00147	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—CCL2—multiple sclerosis	8.78e-05	0.00147	CbGpPWpGaD
Rosiglitazone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.7e-05	0.00145	CbGpPWpGaD
Rosiglitazone—CYP2D6—brain—multiple sclerosis	8.3e-05	0.00856	CbGeAlD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	8.24e-05	0.00137	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	8.19e-05	0.00137	CbGpPWpGaD
Rosiglitazone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8e-05	0.00133	CbGpPWpGaD
Rosiglitazone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.93e-05	0.00132	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—PTPRC—multiple sclerosis	7.92e-05	0.00132	CbGpPWpGaD
Rosiglitazone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.9e-05	0.00132	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SRM—multiple sclerosis	7.88e-05	0.00131	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	7.8e-05	0.0013	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—ZFP36L1—multiple sclerosis	7.71e-05	0.00129	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.64e-05	0.00127	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	7.59e-05	0.00127	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—IFNG—multiple sclerosis	7.47e-05	0.00125	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.28e-05	0.00122	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—STAT3—multiple sclerosis	7.22e-05	0.0012	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.16e-05	0.0012	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.16e-05	0.0012	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.12e-05	0.00119	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.12e-05	0.00119	CbGpPWpGaD
Rosiglitazone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.05e-05	0.00118	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CYP24A1—multiple sclerosis	7.05e-05	0.00118	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CYP27B1—multiple sclerosis	7.05e-05	0.00118	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SRM—multiple sclerosis	7.01e-05	0.00117	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	6.98e-05	0.00116	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	6.97e-05	0.00116	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.89e-05	0.00115	CbGpPWpGaD
Rosiglitazone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.78e-05	0.00113	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.75e-05	0.00113	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—TGFB1—multiple sclerosis	6.69e-05	0.00112	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—IL1B—multiple sclerosis	6.66e-05	0.00111	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—IL2—multiple sclerosis	6.64e-05	0.00111	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SRM—multiple sclerosis	6.63e-05	0.00111	CbGpPWpGaD
Rosiglitazone—PTGS1—Biological oxidations—POMC—multiple sclerosis	6.5e-05	0.00108	CbGpPWpGaD
Rosiglitazone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.48e-05	0.00108	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GPC5—multiple sclerosis	6.45e-05	0.00108	CbGpPWpGaD
Rosiglitazone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.43e-05	0.00107	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.39e-05	0.00107	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.39e-05	0.00107	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PLEK—multiple sclerosis	6.38e-05	0.00106	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—TNF—multiple sclerosis	6.25e-05	0.00104	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.22e-05	0.00104	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.2e-05	0.00103	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—VDR—multiple sclerosis	6.16e-05	0.00103	CbGpPWpGaD
Rosiglitazone—CYP2A6—Biological oxidations—POMC—multiple sclerosis	6.14e-05	0.00102	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—APOE—multiple sclerosis	6.01e-05	0.001	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	5.98e-05	0.000998	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—PABPC1—multiple sclerosis	5.98e-05	0.000997	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	5.94e-05	0.000991	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	5.93e-05	0.00099	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.83e-05	0.000973	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.83e-05	0.000973	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	5.55e-05	0.000926	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	5.55e-05	0.000926	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.52e-05	0.000921	CbGpPWpGaD
Rosiglitazone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.49e-05	0.000917	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.43e-05	0.000905	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—RPL5—multiple sclerosis	5.39e-05	0.0009	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—RRM1—multiple sclerosis	5.34e-05	0.000892	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	5.29e-05	0.000883	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—POMC—multiple sclerosis	5.17e-05	0.000862	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GPC5—multiple sclerosis	5.08e-05	0.000847	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—IL6—multiple sclerosis	5.04e-05	0.000841	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.98e-05	0.000831	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.98e-05	0.000831	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CYP27B1—multiple sclerosis	4.94e-05	0.000824	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CYP24A1—multiple sclerosis	4.94e-05	0.000824	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.84e-05	0.000808	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TNF—multiple sclerosis	4.83e-05	0.000807	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.83e-05	0.000807	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.83e-05	0.000805	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	4.82e-05	0.000805	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	4.79e-05	0.0008	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.78e-05	0.000798	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.74e-05	0.000791	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ALB—multiple sclerosis	4.71e-05	0.000786	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	4.67e-05	0.000779	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	4.67e-05	0.000779	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SRM—multiple sclerosis	4.53e-05	0.000755	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GPC5—multiple sclerosis	4.52e-05	0.000754	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.51e-05	0.000753	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.51e-05	0.000753	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SRM—multiple sclerosis	4.5e-05	0.000751	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SELE—multiple sclerosis	4.49e-05	0.00075	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—TGFB1—multiple sclerosis	4.44e-05	0.000741	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.36e-05	0.000728	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	4.3e-05	0.000718	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GPC5—multiple sclerosis	4.27e-05	0.000713	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—PGR—multiple sclerosis	4.24e-05	0.000708	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	4.23e-05	0.000706	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—RRM1—multiple sclerosis	4.21e-05	0.000702	CbGpPWpGaD
Rosiglitazone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.2e-05	0.0007	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.14e-05	0.000692	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SRM—multiple sclerosis	4.04e-05	0.000674	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	4.04e-05	0.000674	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—IL6—multiple sclerosis	3.9e-05	0.000651	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.86e-05	0.000644	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	3.84e-05	0.000641	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.74e-05	0.000625	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—RRM1—multiple sclerosis	3.74e-05	0.000625	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SRM—multiple sclerosis	3.72e-05	0.00062	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SRM—multiple sclerosis	3.68e-05	0.000615	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.56e-05	0.000594	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—IL6—multiple sclerosis	3.56e-05	0.000594	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TYK2—multiple sclerosis	3.54e-05	0.000591	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—RRM1—multiple sclerosis	3.54e-05	0.000591	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.44e-05	0.000575	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.41e-05	0.00057	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.26e-05	0.000545	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—ITGA4—multiple sclerosis	3.25e-05	0.000542	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.25e-05	0.000542	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IFNB1—multiple sclerosis	3.22e-05	0.000538	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.19e-05	0.000532	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.19e-05	0.000532	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP27B1—multiple sclerosis	3.17e-05	0.000529	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP24A1—multiple sclerosis	3.17e-05	0.000529	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SRM—multiple sclerosis	3.15e-05	0.000525	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.12e-05	0.00052	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.1e-05	0.000517	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	3.1e-05	0.000517	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—BCHE—multiple sclerosis	3.07e-05	0.000512	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—VDR—multiple sclerosis	2.97e-05	0.000495	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.92e-05	0.000487	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.92e-05	0.000487	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.9e-05	0.000485	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPC5—multiple sclerosis	2.9e-05	0.000484	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.85e-05	0.000475	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.85e-05	0.000475	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.8e-05	0.000468	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MMP9—multiple sclerosis	2.79e-05	0.000466	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.78e-05	0.000464	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.62e-05	0.000437	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.62e-05	0.000437	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.6e-05	0.000435	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.6e-05	0.000433	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.6e-05	0.000433	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.56e-05	0.000427	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.54e-05	0.000423	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	2.52e-05	0.000421	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.49e-05	0.000416	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—STAT3—multiple sclerosis	2.48e-05	0.000414	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—MYC—multiple sclerosis	2.45e-05	0.000409	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.43e-05	0.000406	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.42e-05	0.000403	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—BCHE—multiple sclerosis	2.42e-05	0.000403	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—RRM1—multiple sclerosis	2.4e-05	0.000401	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.4e-05	0.0004	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.37e-05	0.000396	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TGFB1—multiple sclerosis	2.3e-05	0.000384	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.27e-05	0.000379	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MAPK1—multiple sclerosis	2.25e-05	0.000376	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IL2RA—multiple sclerosis	2.22e-05	0.00037	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.22e-05	0.00037	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.22e-05	0.00037	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.17e-05	0.000362	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.16e-05	0.00036	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—BCHE—multiple sclerosis	2.15e-05	0.000359	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TNF—multiple sclerosis	2.15e-05	0.000358	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—BCHE—multiple sclerosis	2.03e-05	0.000339	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.03e-05	0.000339	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.98e-05	0.000331	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.97e-05	0.000329	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.97e-05	0.000328	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.93e-05	0.000322	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.88e-05	0.000313	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.86e-05	0.000311	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—APOE—multiple sclerosis	1.85e-05	0.000308	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—IL6—multiple sclerosis	1.73e-05	0.000289	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.68e-05	0.000281	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.67e-05	0.000279	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.61e-05	0.000269	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.6e-05	0.000267	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—POMC—multiple sclerosis	1.59e-05	0.000265	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.53e-05	0.000255	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.47e-05	0.000245	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—APOE—multiple sclerosis	1.45e-05	0.000243	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—multiple sclerosis	1.45e-05	0.000241	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.44e-05	0.00024	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.39e-05	0.000232	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—BCHE—multiple sclerosis	1.38e-05	0.00023	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.31e-05	0.000219	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.31e-05	0.000219	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.3e-05	0.000218	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IL2—multiple sclerosis	1.3e-05	0.000217	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOE—multiple sclerosis	1.29e-05	0.000216	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—POMC—multiple sclerosis	1.25e-05	0.000208	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.24e-05	0.000207	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOE—multiple sclerosis	1.22e-05	0.000204	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.2e-05	0.000199	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—multiple sclerosis	1.18e-05	0.000197	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.00019	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—multiple sclerosis	1.14e-05	0.00019	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.000189	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	0.000187	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—POMC—multiple sclerosis	1.11e-05	0.000185	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—POMC—multiple sclerosis	1.05e-05	0.000175	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.02e-05	0.00017	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—multiple sclerosis	1.01e-05	0.000169	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—multiple sclerosis	1.01e-05	0.000169	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK1—multiple sclerosis	9.95e-06	0.000166	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.66e-06	0.000161	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—multiple sclerosis	9.58e-06	0.00016	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOE—multiple sclerosis	8.35e-06	0.000139	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOE—multiple sclerosis	8.3e-06	0.000139	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOE—multiple sclerosis	7.46e-06	0.000124	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—POMC—multiple sclerosis	7.18e-06	0.00012	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—POMC—multiple sclerosis	7.13e-06	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOE—multiple sclerosis	6.86e-06	0.000114	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOE—multiple sclerosis	6.8e-06	0.000113	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—multiple sclerosis	6.54e-06	0.000109	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—POMC—multiple sclerosis	6.4e-06	0.000107	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—POMC—multiple sclerosis	5.89e-06	9.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—POMC—multiple sclerosis	5.84e-06	9.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—multiple sclerosis	5.84e-06	9.74e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOE—multiple sclerosis	5.81e-06	9.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—multiple sclerosis	5.37e-06	8.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—multiple sclerosis	5.32e-06	8.88e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—POMC—multiple sclerosis	4.99e-06	8.33e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—multiple sclerosis	4.55e-06	7.59e-05	CbGpPWpGaD
